First-Line Antibiotic for Bronchitis
For acute bronchitis in previously healthy adults, antibiotics are NOT routinely recommended as this is primarily a viral illness. 1
When Antibiotics Are NOT Indicated
- Previously well adults with acute bronchitis do not require antibiotics in the absence of pneumonia, as acute bronchitis is predominantly viral in etiology 1
- Routine antibiotic treatment is not justified and should not be offered for uncomplicated acute bronchitis 1
- The decision not to prescribe antibiotics should be explained to patients, as many expect antibiotics based on prior experiences 1
When Antibiotics ARE Indicated
Antibiotics should be considered in specific circumstances:
For Acute Exacerbations of Chronic Bronchitis (COPD)
Co-amoxiclav (amoxicillin-clavulanate) 625 mg three times daily orally is the preferred first-line antibiotic for patients with chronic lung disease (particularly COPD) experiencing bacterial exacerbations requiring hospital admission 1
Alternative first-line options include:
- Doxycycline 200 mg loading dose, then 100 mg once daily 1
- Azithromycin 500 mg once daily for 3 days 2, 3, 4
Rationale for Antibiotic Selection
The preferred antibiotics must cover the most likely bacterial pathogens:
Co-amoxiclav is preferred because:
- It is a beta-lactamase stable agent effective against all common respiratory pathogens 1
- It provides reliable coverage for H. influenzae, which produces beta-lactamase 1
Doxycycline is an effective alternative:
- Particularly useful for patients with beta-lactam allergies 1
- Provides adequate coverage for typical respiratory pathogens 1
Azithromycin advantages:
- Single daily dosing improves compliance 5, 4
- Short 3-day course (500 mg daily) is as effective as 10-day courses of other antibiotics 3, 4
- Clinical cure rates of 86-92% in acute exacerbations of chronic bronchitis 2, 3
- Better tolerated with fewer gastrointestinal side effects than co-amoxiclav 4
Alternative Antibiotics for Specific Situations
For patients intolerant of first-line options:
- Macrolides: Clarithromycin 500 mg twice daily (preferred over erythromycin for better H. influenzae activity and twice-daily dosing) 1
- Fluoroquinolones: Levofloxacin 500 mg once daily or moxifloxacin 400 mg once daily (reserved for increased likelihood of resistance or local resistance patterns) 1, 6
Important Caveats
Pertussis (Whooping Cough) Exception
If pertussis is suspected or confirmed, a macrolide antibiotic (erythromycin or azithromycin) is mandatory 1
- Treatment must be initiated early (within first few weeks) to reduce coughing paroxysms and prevent disease spread 1
- Patient isolation for 5 days from start of treatment is required 1
Pediatric Considerations
- In children under 3 years with bronchitis requiring antibiotics: amoxicillin 80-100 mg/kg/day in three divided doses 1
- In children over 3 years: macrolides may be considered if atypical pathogens (Mycoplasma or Chlamydia) are suspected 1
Common Pitfalls to Avoid
- Do not prescribe fluoroquinolones as first-line therapy unless there are specific resistance concerns or contraindications to preferred agents 1
- Avoid aminoglycosides in patients with renal impairment due to nephrotoxicity risk 7
- Remember that in vitro resistance may not correlate with clinical failure, particularly for macrolides in chronic suppressive therapy 1
- Bronchodilators are not routinely recommended for acute bronchitis unless wheezing is present 1